Furthermore, this DC state has been found to be enriched in cases of microsatellite instability-high CRC [41], suggesting that CCL22+ cDC1s may serve as a valuable biomarker for assessing the efficacy of immunotherapy in CRC. The gene discussed is CCL22; the disease is colorectal carcinoma.